Working… Menu

Study of the Efficacy and Safety of Tesevatinib in Subjects With ADPKD

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03203642
Recruitment Status : Recruiting
First Posted : June 29, 2017
Last Update Posted : October 31, 2019
Information provided by (Responsible Party):
Kadmon Corporation, LLC

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 10, 2020
Estimated Study Completion Date : August 10, 2020